Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Antiarrhythmic Drugs.

Singh SN, Patrick J, Patrick J.

Curr Treat Options Cardiovasc Med. 2004 Oct;6(5):357-364.

PMID:
15324611
2.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
3.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
4.

Amiodarone -- waxed and waned and waxed again.

Doggrell SA.

Expert Opin Pharmacother. 2001 Nov;2(11):1877-90. Review.

PMID:
11825323
5.

A benefit-risk assessment of class III antiarrhythmic agents.

Brendorp B, Pedersen O, Torp-Pedersen C, Sahebzadah N, Køber L.

Drug Saf. 2002;25(12):847-65. Review.

PMID:
12241126
6.

Current treatment recommendations in antiarrhythmic therapy.

Van Gelder IC, Brügemann J, Crijns HJ.

Drugs. 1998 Mar;55(3):331-46. Review.

PMID:
9530541
7.

Novel approaches for pharmacological management of atrial fibrillation.

Ehrlich JR, Nattel S.

Drugs. 2009;69(7):757-74. doi: 10.2165/00003495-200969070-00001. Review.

PMID:
19441867
8.

Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.

Ho AT, Pai SM, Timothy P, Pai RG.

Pacing Clin Electrophysiol. 2005 Jul;28(7):647-53.

PMID:
16008799
9.

Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.

Ellison KE, Gandhi G.

Drugs. 2005;65(6):787-97. Review.

PMID:
15819591
10.

Atrial Flutter.

Garg A, Feld GK.

Curr Treat Options Cardiovasc Med. 2001 Aug;3(4):277-289.

PMID:
11445058
11.

[Arterial hypertension and cardiac arrhythmias].

Vester EG.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S261-5. doi: 10.1055/s-0028-1100958. Epub 2008 Dec 15. Review. German.

PMID:
19085803
12.

Clinical efficacy of amiodarone.

Nolan PE Jr, Nappi J, Pollak PT.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):127S-137S. Review.

PMID:
9855345
13.

Effect of drugs on defibrillation capacity.

Dopp AL, Miller JM, Tisdale JE.

Drugs. 2008;68(5):607-30. Review.

PMID:
18370441
14.
15.

[The patient at risk of sudden death:value of drug therapy].

Bonhorst D.

Rev Port Cardiol. 2000 Feb;19(2):233-9. Review. Portuguese.

PMID:
10763353
16.

A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.

Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G; PITAGORA Study Investigators..

Am Heart J. 2008 Jan;155(1):100-7, 107.e1. Epub 2007 Nov 26.

PMID:
18082498
17.

Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.

Meinertz T, Hofmann T, Zehender M, Drexler H, Hohnloser S, Just H.

J Cardiovasc Pharmacol. 1990;16 Suppl 5:S151-7. Review.

PMID:
11527120
18.

[Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].

Iturralde Torres P.

Arch Cardiol Mex. 2007 Oct-Dec;77 Suppl 4:S4-129-32. Spanish.

PMID:
18938711
19.

Arrhythmias in Patients with Heart Failure.

Hynes BJ, Luck JC, Wolbrette DL, Boehmer J, Naccarelli GV.

Curr Treat Options Cardiovasc Med. 2002 Dec;4(6):467-485.

PMID:
12408789
20.

Atrial fibrillation: choosing an antiarrhythmic drug.

Rudo T, Kowey P.

Curr Cardiol Rep. 2006 Sep;8(5):370-6. Review.

PMID:
16956453

Supplemental Content

Support Center